Dentists in Bardstown, KY Accepting Medicare
27 Dentists found. Showing 21 - 27
 Dr. Lauren Michelle Hedgespeth, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 798 Portland Ave, Bardstown, KY 40004 Phone: 502-348-7378 |
 Ronald G Shrewsbury, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 621 N 3rd Street, Bardstown, KY 40004 Phone: 502-348-5901 Fax: 502-348-7260 |
Dr. Michael E Harris, DDS MSD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 218 W John Fitch Ave, Bardstown, KY 40004 Phone: 502-348-9775 Fax: 502-348-2756 |
Matthew T Morgan, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 625 North Third St, Bardstown, KY 40004 Phone: 502-348-5901 Fax: 502-348-7260 |
Dr. Alyssa Claire Farmer, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 919 Chambers Blvd, Bardstown, KY 40004 Phone: 502-348-6404 |
Dr. Michael L. Hunt, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1000 E John Rowan Blvd Ste 101, Bardstown, KY 40004 Phone: 502-348-2589 |
Cailan Christopher Jones, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 810 Morton Ave Ste 200, Bardstown, KY 40004 Phone: 502-348-9944 |
News Archive
Studies show biological agents play important role in maintaining remission in Crohn's disease
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
IU School of Medicine researchers identify new protein that can control diabetes
Indiana University School of Medicine researchers have identified a small protein with a big role in lowering plasma glucose and increasing insulin sensitivity.
Medical device manufacturers launch ad to head off $40B tax on their products
The Medical Device Manufacturers Association is starting a $200,000 radio and print ad campaign aimed at stopping Congress from imposing more than $40 billion in taxes on their goods, Roll Call reports.
Beckman Coulter Life Sciences contributes its flow cytometry expertise to support the ONE Study
Beckman Coulter Life Sciences participates in the ONE Study, international collaboration of scientists across Europe and the USA.
› Verified 1 days ago
- 1
- 2(current)
Counselors
Dentists
Occupational Therapists
Pharmacists
Clinical Social Workers
Psychologists